ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Jakinibs Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-24I963
Home | Market Reports | Health| Pharmacy
Global Jakinibs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Jakinibs Market Research Report 2025

Code: QYRE-Auto-24I963
Report
July 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Astellas Pharma Inc
Eli Lilly and Co
Incyte Corp
Novartis
Pfizer Inc
GSK
Bristol-Myers Squibb Co
Baxter International Inc
Gilead Sciences Inc
AbbVie
Takeda
Boehringer Ingelheim group
Teva Pharmaceutical
Kyowa Hakko Kirin Co Ltd

The global market for Jakinibs was valued at US$ 18310 million in the year 2024 and is projected to reach a revised size of US$ 41040 million by 2031, growing at a CAGR of 12.4% during the forecast period.

Jakinibs Market

Jakinibs Market

Jakinibs are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.
The driving factors of the Janus Kinase (JAK) inhibitor market mainly include the following aspects:
Increase in immune system diseases: JAK inhibitors are commonly used to treat immune system-related diseases such as rheumatoid arthritis, Sjogren"s syndrome, inflammatory bowel disease, and psoriasis. As the incidence of these diseases continues to increase, the JAK inhibitor market is also expanding.
Research and development of innovative drugs: Pharmaceutical companies continue to invest in the development of new generations of JAK inhibitors to improve treatment efficacy and reduce side effects. The launch of these innovative drugs drives the growth of the market.
Aging Global Population: As the global population ages, the risk of developing immune system-related diseases increases. This will drive demand for drugs such as JAK inhibitors to address health challenges in the elderly population.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Jakinibs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Jakinibs.
The Jakinibs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Jakinibs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Jakinibs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Jakinibs Market Report

Report Metric Details
Report Name Jakinibs Market
Accounted market size in year US$ 18310 million
Forecasted market size in 2031 US$ 41040 million
CAGR 12.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • JAK1 Inhibitors
  • JAK2 Inhibitors
  • JAK3 Inhibitors
Segment by Application
  • Rheumatoid Arthritis
  • Inflammatory Bowel Disease
  • Psoriasis
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Astellas Pharma, Inc., Eli Lilly and Co., Incyte Corp., Novartis AG, Pfizer Inc., GSK, Bristol Myers Squibb Co., Baxter International, Inc., Gilead Sciences, Inc., AbbVie, Inc., Takeda, Boehringer Ingelheim Group, Teva Pharmaceutical, Kyowa Hakko Kirin Co. Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Jakinibs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Jakinibs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Jakinibs Market growing?

Ans: The Jakinibs Market witnessing a CAGR of 12.4% during the forecast period 2025-2031.

What is the Jakinibs Market size in 2031?

Ans: The Jakinibs Market size in 2031 will be US$ 41040 million.

Who are the main players in the Jakinibs Market report?

Ans: The main players in the Jakinibs Market are Astellas Pharma, Inc., Eli Lilly and Co., Incyte Corp., Novartis AG, Pfizer Inc., GSK, Bristol Myers Squibb Co., Baxter International, Inc., Gilead Sciences, Inc., AbbVie, Inc., Takeda, Boehringer Ingelheim Group, Teva Pharmaceutical, Kyowa Hakko Kirin Co. Ltd.

What are the Application segmentation covered in the Jakinibs Market report?

Ans: The Applications covered in the Jakinibs Market report are Rheumatoid Arthritis, Inflammatory Bowel Disease, Psoriasis, Others

What are the Type segmentation covered in the Jakinibs Market report?

Ans: The Types covered in the Jakinibs Market report are JAK1 Inhibitors, JAK2 Inhibitors, JAK3 Inhibitors

Recommended Reports

JAK Inhibitor Drugs

Kinase Inhibitor Therapeutics

Autoimmune Therapeutics

1 Jakinibs Market Overview
1.1 Product Definition
1.2 Jakinibs by Type
1.2.1 Global Jakinibs Market Value Comparison by Type (2024 VS 2031)
1.2.2 JAK1 Inhibitors
1.2.3 JAK2 Inhibitors
1.2.4 JAK3 Inhibitors
1.3 Jakinibs by Application
1.3.1 Global Jakinibs Market Value by Application (2024 VS 2031)
1.3.2 Rheumatoid Arthritis
1.3.3 Inflammatory Bowel Disease
1.3.4 Psoriasis
1.3.5 Others
1.4 Global Jakinibs Market Size Estimates and Forecasts
1.4.1 Global Jakinibs Revenue 2020-2031
1.4.2 Global Jakinibs Sales 2020-2031
1.4.3 Global Jakinibs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Jakinibs Market Competition by Manufacturers
2.1 Global Jakinibs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Jakinibs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Jakinibs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Jakinibs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Jakinibs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Jakinibs, Product Type & Application
2.7 Global Key Manufacturers of Jakinibs, Date of Enter into This Industry
2.8 Global Jakinibs Market Competitive Situation and Trends
2.8.1 Global Jakinibs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Jakinibs Players Market Share by Revenue
2.8.3 Global Jakinibs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Jakinibs Market Scenario by Region
3.1 Global Jakinibs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Jakinibs Sales by Region: 2020-2031
3.2.1 Global Jakinibs Sales by Region: 2020-2025
3.2.2 Global Jakinibs Sales by Region: 2026-2031
3.3 Global Jakinibs Revenue by Region: 2020-2031
3.3.1 Global Jakinibs Revenue by Region: 2020-2025
3.3.2 Global Jakinibs Revenue by Region: 2026-2031
3.4 North America Jakinibs Market Facts & Figures by Country
3.4.1 North America Jakinibs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Jakinibs Sales by Country (2020-2031)
3.4.3 North America Jakinibs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Jakinibs Market Facts & Figures by Country
3.5.1 Europe Jakinibs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Jakinibs Sales by Country (2020-2031)
3.5.3 Europe Jakinibs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Jakinibs Market Facts & Figures by Region
3.6.1 Asia Pacific Jakinibs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Jakinibs Sales by Region (2020-2031)
3.6.3 Asia Pacific Jakinibs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Jakinibs Market Facts & Figures by Country
3.7.1 Latin America Jakinibs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Jakinibs Sales by Country (2020-2031)
3.7.3 Latin America Jakinibs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Jakinibs Market Facts & Figures by Country
3.8.1 Middle East and Africa Jakinibs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Jakinibs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Jakinibs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Jakinibs Sales by Type (2020-2031)
4.1.1 Global Jakinibs Sales by Type (2020-2025)
4.1.2 Global Jakinibs Sales by Type (2026-2031)
4.1.3 Global Jakinibs Sales Market Share by Type (2020-2031)
4.2 Global Jakinibs Revenue by Type (2020-2031)
4.2.1 Global Jakinibs Revenue by Type (2020-2025)
4.2.2 Global Jakinibs Revenue by Type (2026-2031)
4.2.3 Global Jakinibs Revenue Market Share by Type (2020-2031)
4.3 Global Jakinibs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Jakinibs Sales by Application (2020-2031)
5.1.1 Global Jakinibs Sales by Application (2020-2025)
5.1.2 Global Jakinibs Sales by Application (2026-2031)
5.1.3 Global Jakinibs Sales Market Share by Application (2020-2031)
5.2 Global Jakinibs Revenue by Application (2020-2031)
5.2.1 Global Jakinibs Revenue by Application (2020-2025)
5.2.2 Global Jakinibs Revenue by Application (2026-2031)
5.2.3 Global Jakinibs Revenue Market Share by Application (2020-2031)
5.3 Global Jakinibs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Astellas Pharma, Inc.
6.1.1 Astellas Pharma, Inc. Company Information
6.1.2 Astellas Pharma, Inc. Description and Business Overview
6.1.3 Astellas Pharma, Inc. Jakinibs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Astellas Pharma, Inc. Jakinibs Product Portfolio
6.1.5 Astellas Pharma, Inc. Recent Developments/Updates
6.2 Eli Lilly and Co.
6.2.1 Eli Lilly and Co. Company Information
6.2.2 Eli Lilly and Co. Description and Business Overview
6.2.3 Eli Lilly and Co. Jakinibs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Eli Lilly and Co. Jakinibs Product Portfolio
6.2.5 Eli Lilly and Co. Recent Developments/Updates
6.3 Incyte Corp.
6.3.1 Incyte Corp. Company Information
6.3.2 Incyte Corp. Description and Business Overview
6.3.3 Incyte Corp. Jakinibs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Incyte Corp. Jakinibs Product Portfolio
6.3.5 Incyte Corp. Recent Developments/Updates
6.4 Novartis AG
6.4.1 Novartis AG Company Information
6.4.2 Novartis AG Description and Business Overview
6.4.3 Novartis AG Jakinibs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novartis AG Jakinibs Product Portfolio
6.4.5 Novartis AG Recent Developments/Updates
6.5 Pfizer Inc.
6.5.1 Pfizer Inc. Company Information
6.5.2 Pfizer Inc. Description and Business Overview
6.5.3 Pfizer Inc. Jakinibs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Pfizer Inc. Jakinibs Product Portfolio
6.5.5 Pfizer Inc. Recent Developments/Updates
6.6 GSK
6.6.1 GSK Company Information
6.6.2 GSK Description and Business Overview
6.6.3 GSK Jakinibs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GSK Jakinibs Product Portfolio
6.6.5 GSK Recent Developments/Updates
6.7 Bristol Myers Squibb Co.
6.7.1 Bristol Myers Squibb Co. Company Information
6.7.2 Bristol Myers Squibb Co. Description and Business Overview
6.7.3 Bristol Myers Squibb Co. Jakinibs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bristol Myers Squibb Co. Jakinibs Product Portfolio
6.7.5 Bristol Myers Squibb Co. Recent Developments/Updates
6.8 Baxter International, Inc.
6.8.1 Baxter International, Inc. Company Information
6.8.2 Baxter International, Inc. Description and Business Overview
6.8.3 Baxter International, Inc. Jakinibs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Baxter International, Inc. Jakinibs Product Portfolio
6.8.5 Baxter International, Inc. Recent Developments/Updates
6.9 Gilead Sciences, Inc.
6.9.1 Gilead Sciences, Inc. Company Information
6.9.2 Gilead Sciences, Inc. Description and Business Overview
6.9.3 Gilead Sciences, Inc. Jakinibs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Gilead Sciences, Inc. Jakinibs Product Portfolio
6.9.5 Gilead Sciences, Inc. Recent Developments/Updates
6.10 AbbVie, Inc.
6.10.1 AbbVie, Inc. Company Information
6.10.2 AbbVie, Inc. Description and Business Overview
6.10.3 AbbVie, Inc. Jakinibs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 AbbVie, Inc. Jakinibs Product Portfolio
6.10.5 AbbVie, Inc. Recent Developments/Updates
6.11 Takeda
6.11.1 Takeda Company Information
6.11.2 Takeda Description and Business Overview
6.11.3 Takeda Jakinibs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Takeda Jakinibs Product Portfolio
6.11.5 Takeda Recent Developments/Updates
6.12 Boehringer Ingelheim Group
6.12.1 Boehringer Ingelheim Group Company Information
6.12.2 Boehringer Ingelheim Group Description and Business Overview
6.12.3 Boehringer Ingelheim Group Jakinibs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Boehringer Ingelheim Group Jakinibs Product Portfolio
6.12.5 Boehringer Ingelheim Group Recent Developments/Updates
6.13 Teva Pharmaceutical
6.13.1 Teva Pharmaceutical Company Information
6.13.2 Teva Pharmaceutical Description and Business Overview
6.13.3 Teva Pharmaceutical Jakinibs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Teva Pharmaceutical Jakinibs Product Portfolio
6.13.5 Teva Pharmaceutical Recent Developments/Updates
6.14 Kyowa Hakko Kirin Co. Ltd.
6.14.1 Kyowa Hakko Kirin Co. Ltd. Company Information
6.14.2 Kyowa Hakko Kirin Co. Ltd. Description and Business Overview
6.14.3 Kyowa Hakko Kirin Co. Ltd. Jakinibs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Kyowa Hakko Kirin Co. Ltd. Jakinibs Product Portfolio
6.14.5 Kyowa Hakko Kirin Co. Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Jakinibs Industry Chain Analysis
7.2 Jakinibs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Jakinibs Production Mode & Process Analysis
7.4 Jakinibs Sales and Marketing
7.4.1 Jakinibs Sales Channels
7.4.2 Jakinibs Distributors
7.5 Jakinibs Customer Analysis
8 Jakinibs Market Dynamics
8.1 Jakinibs Industry Trends
8.2 Jakinibs Market Drivers
8.3 Jakinibs Market Challenges
8.4 Jakinibs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Astellas Pharma Inc
Eli Lilly and Co
Incyte Corp
Novartis
Pfizer Inc
GSK
Bristol-Myers Squibb Co
Baxter International Inc
Gilead Sciences Inc
AbbVie
Takeda
Boehringer Ingelheim group
Teva Pharmaceutical
Kyowa Hakko Kirin Co Ltd
List of Tables
 Table 1. Global Jakinibs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Jakinibs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Jakinibs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Jakinibs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Jakinibs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Jakinibs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Jakinibs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Jakinibs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Jakinibs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Jakinibs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Jakinibs, Product Type & Application
 Table 12. Global Key Manufacturers of Jakinibs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Jakinibs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Jakinibs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Jakinibs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Jakinibs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Jakinibs Sales Market Share by Region (2020-2025)
 Table 19. Global Jakinibs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Jakinibs Sales Market Share by Region (2026-2031)
 Table 21. Global Jakinibs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Jakinibs Revenue Market Share by Region (2020-2025)
 Table 23. Global Jakinibs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Jakinibs Revenue Market Share by Region (2026-2031)
 Table 25. North America Jakinibs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Jakinibs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Jakinibs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Jakinibs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Jakinibs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Jakinibs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Jakinibs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Jakinibs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Jakinibs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Jakinibs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Jakinibs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Jakinibs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Jakinibs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Jakinibs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Jakinibs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Jakinibs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Jakinibs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Jakinibs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Jakinibs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Jakinibs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Jakinibs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Jakinibs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Jakinibs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Jakinibs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Jakinibs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Jakinibs Sales (K Units) by Type (2020-2025)
 Table 51. Global Jakinibs Sales (K Units) by Type (2026-2031)
 Table 52. Global Jakinibs Sales Market Share by Type (2020-2025)
 Table 53. Global Jakinibs Sales Market Share by Type (2026-2031)
 Table 54. Global Jakinibs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Jakinibs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Jakinibs Revenue Market Share by Type (2020-2025)
 Table 57. Global Jakinibs Revenue Market Share by Type (2026-2031)
 Table 58. Global Jakinibs Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Jakinibs Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Jakinibs Sales (K Units) by Application (2020-2025)
 Table 61. Global Jakinibs Sales (K Units) by Application (2026-2031)
 Table 62. Global Jakinibs Sales Market Share by Application (2020-2025)
 Table 63. Global Jakinibs Sales Market Share by Application (2026-2031)
 Table 64. Global Jakinibs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Jakinibs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Jakinibs Revenue Market Share by Application (2020-2025)
 Table 67. Global Jakinibs Revenue Market Share by Application (2026-2031)
 Table 68. Global Jakinibs Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Jakinibs Price (USD/Unit) by Application (2026-2031)
 Table 70. Astellas Pharma, Inc. Company Information
 Table 71. Astellas Pharma, Inc. Description and Business Overview
 Table 72. Astellas Pharma, Inc. Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Astellas Pharma, Inc. Jakinibs Product
 Table 74. Astellas Pharma, Inc. Recent Developments/Updates
 Table 75. Eli Lilly and Co. Company Information
 Table 76. Eli Lilly and Co. Description and Business Overview
 Table 77. Eli Lilly and Co. Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Eli Lilly and Co. Jakinibs Product
 Table 79. Eli Lilly and Co. Recent Developments/Updates
 Table 80. Incyte Corp. Company Information
 Table 81. Incyte Corp. Description and Business Overview
 Table 82. Incyte Corp. Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Incyte Corp. Jakinibs Product
 Table 84. Incyte Corp. Recent Developments/Updates
 Table 85. Novartis AG Company Information
 Table 86. Novartis AG Description and Business Overview
 Table 87. Novartis AG Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Novartis AG Jakinibs Product
 Table 89. Novartis AG Recent Developments/Updates
 Table 90. Pfizer Inc. Company Information
 Table 91. Pfizer Inc. Description and Business Overview
 Table 92. Pfizer Inc. Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Pfizer Inc. Jakinibs Product
 Table 94. Pfizer Inc. Recent Developments/Updates
 Table 95. GSK Company Information
 Table 96. GSK Description and Business Overview
 Table 97. GSK Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. GSK Jakinibs Product
 Table 99. GSK Recent Developments/Updates
 Table 100. Bristol Myers Squibb Co. Company Information
 Table 101. Bristol Myers Squibb Co. Description and Business Overview
 Table 102. Bristol Myers Squibb Co. Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Bristol Myers Squibb Co. Jakinibs Product
 Table 104. Bristol Myers Squibb Co. Recent Developments/Updates
 Table 105. Baxter International, Inc. Company Information
 Table 106. Baxter International, Inc. Description and Business Overview
 Table 107. Baxter International, Inc. Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Baxter International, Inc. Jakinibs Product
 Table 109. Baxter International, Inc. Recent Developments/Updates
 Table 110. Gilead Sciences, Inc. Company Information
 Table 111. Gilead Sciences, Inc. Description and Business Overview
 Table 112. Gilead Sciences, Inc. Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Gilead Sciences, Inc. Jakinibs Product
 Table 114. Gilead Sciences, Inc. Recent Developments/Updates
 Table 115. AbbVie, Inc. Company Information
 Table 116. AbbVie, Inc. Description and Business Overview
 Table 117. AbbVie, Inc. Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. AbbVie, Inc. Jakinibs Product
 Table 119. AbbVie, Inc. Recent Developments/Updates
 Table 120. Takeda Company Information
 Table 121. Takeda Description and Business Overview
 Table 122. Takeda Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Takeda Jakinibs Product
 Table 124. Takeda Recent Developments/Updates
 Table 125. Boehringer Ingelheim Group Company Information
 Table 126. Boehringer Ingelheim Group Description and Business Overview
 Table 127. Boehringer Ingelheim Group Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Boehringer Ingelheim Group Jakinibs Product
 Table 129. Boehringer Ingelheim Group Recent Developments/Updates
 Table 130. Teva Pharmaceutical Company Information
 Table 131. Teva Pharmaceutical Description and Business Overview
 Table 132. Teva Pharmaceutical Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 133. Teva Pharmaceutical Jakinibs Product
 Table 134. Teva Pharmaceutical Recent Developments/Updates
 Table 135. Kyowa Hakko Kirin Co. Ltd. Company Information
 Table 136. Kyowa Hakko Kirin Co. Ltd. Description and Business Overview
 Table 137. Kyowa Hakko Kirin Co. Ltd. Jakinibs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 138. Kyowa Hakko Kirin Co. Ltd. Jakinibs Product
 Table 139. Kyowa Hakko Kirin Co. Ltd. Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Jakinibs Distributors List
 Table 143. Jakinibs Customers List
 Table 144. Jakinibs Market Trends
 Table 145. Jakinibs Market Drivers
 Table 146. Jakinibs Market Challenges
 Table 147. Jakinibs Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Jakinibs
 Figure 2. Global Jakinibs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Jakinibs Market Share by Type: 2024 & 2031
 Figure 4. JAK1 Inhibitors Product Picture
 Figure 5. JAK2 Inhibitors Product Picture
 Figure 6. JAK3 Inhibitors Product Picture
 Figure 7. Global Jakinibs Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Jakinibs Market Share by Application: 2024 & 2031
 Figure 9. Rheumatoid Arthritis
 Figure 10. Inflammatory Bowel Disease
 Figure 11. Psoriasis
 Figure 12. Others
 Figure 13. Global Jakinibs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Jakinibs Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Jakinibs Sales (2020-2031) & (K Units)
 Figure 16. Global Jakinibs Average Price (USD/Unit) & (2020-2031)
 Figure 17. Jakinibs Report Years Considered
 Figure 18. Jakinibs Sales Share by Manufacturers in 2024
 Figure 19. Global Jakinibs Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Jakinibs Players: Market Share by Revenue in Jakinibs in 2024
 Figure 21. Jakinibs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Jakinibs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Jakinibs Sales Market Share by Country (2020-2031)
 Figure 24. North America Jakinibs Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Jakinibs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Jakinibs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Jakinibs Sales Market Share by Country (2020-2031)
 Figure 28. Europe Jakinibs Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Jakinibs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Jakinibs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Jakinibs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Jakinibs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Jakinibs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Jakinibs Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Jakinibs Revenue Market Share by Region (2020-2031)
 Figure 36. China Jakinibs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Jakinibs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Jakinibs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Jakinibs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Jakinibs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Jakinibs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Jakinibs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Jakinibs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Jakinibs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Jakinibs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Jakinibs Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Jakinibs Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Jakinibs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Jakinibs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Jakinibs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Jakinibs Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Jakinibs Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Jakinibs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Jakinibs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Jakinibs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Jakinibs by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Jakinibs by Type (2020-2031)
 Figure 58. Global Jakinibs Price (USD/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Jakinibs by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Jakinibs by Application (2020-2031)
 Figure 61. Global Jakinibs Price (USD/Unit) by Application (2020-2031)
 Figure 62. Jakinibs Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Janus Kinase JAK Inhibitors Market Insights Forecast to 2030
Tyrosine Kinase JAK Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Janus Kinase Inhibitors Market Research Report 2024
JAK1 Inhibitor Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Janus Kinase inhibitors JAKi Market Research Report 2024
Oral JAK1 Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ruxolitinib Drugs Market Research Report 2024
Global Oral JAK Inhibitors Market Research Report 2024
Global Momelotinib Market Research Report 2024
Global Filgotinib Tablets Market Research Report 2024
Global TKIs for Breast Cancer Market Research Report 2024
Global Tyrosine Kinase Inhibitors Market Research Report 2024
Global Small Molecule Targeted Drugs for Allergic Diseases Market Research Report 2024
JAK Inhibitor Based Cancer Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Kinase Inhibitors For Cancer Treatment Market Research Report 2024
Global Janus Kinase JAK Inhibitor for for Alopecia Areata Market Research Report 2025
Global Janus Kinases Inhibitor Drugs Market Research Report 2024
Global Phosphoinositide 3 Kinase PI3K Inhibitors Market Insights Forecast to 2030
Nilotinib Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Radotinib Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions